COVID-19 Current Therapy Market Report 2026
Download Free Sample Buy Now
COVID-19 Current Therapy Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

COVID-19 Current Therapy Market Report 2026

Global Outlook – By Drug Type (Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs), By Route Of Administration (Oral, Intravenous), By End-User (Hospitals, Clinics, Home Care, Others) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

COVID-19 Current Therapy Market Overview

• COVID-19 Current Therapy market size has reached to $2.35 billion in 2025

• Expected to grow to $0.31 billion in 2030 at a compound annual growth rate (CAGR) of 0%

• Growth Driver: Healthcare Infrastructure Expansion Fueling Growth In The COVID-19 Current Therapy Market

• Market Trend: Innovation In COVID-19 Therapies On Oral Antiviral Treatments By Major Pharmaceutical Companies

• North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under COVID-19 Current Therapy Market?

COVID-19 Current Therapy refers to the treatments and interventions used to manage symptoms and reduce the severity of COVID-19. It is used to alleviate respiratory distress, prevent complications, and support recovery in affected individuals. Key therapies include antiviral medications, corticosteroids, and supportive care.

The main types of drugs in COVID-19 current therapy are antiviral, monoclonal antibodies, corticosteroids, supplements, antimalarial, interferons and interleukin inhibitors, other anti-infective drugs, and others. Antivirals are a class of medications or substances designed to inhibit the growth and replication of viruses. These agents are used to treat viral infections by targeting specific stages of the viral life cycle or interfering with viral processes. It can be administered through various routes such as oral and intravenous. The different sectors include hospitals, clinics, research institutes, and others.

COVID-19 Current Therapy Market Global Report 2026 Market Report bar graph

What Is The COVID-19 Current Therapy Market Size and Share 2026?

The covid-19 current therapy market size has declined steeply in recent years. It will decline from $2.35 billion in 2025 to $1.57 billion in 2026 at a compound annual growth rate (CAGR) of -33.2%. The decline in the historic period can be attributed to sudden outbreak of covid-19, high hospitalization rates, limited initial therapeutic options, decreasing government and healthcare initiatives, less emergency approvals for drugs.

What Is The COVID-19 Current Therapy Market Growth Forecast?

The covid-19 current therapy market size is expected to see steep decline in the next few years. It will decline to $0.31 billion in 2030 at a compound annual growth rate (CAGR) of -33.2%. The decline in the forecast period can be attributed to decreasing telemedicine adoption for covid-19 management, less expansion of home care services. Major trends in the forecast period include rising adoption of antiviral and monoclonal antibody therapies, increased use of corticosteroids for severe covid-19 cases, growth in home care and remote patient monitoring for covid-19, expansion of supplement and immune support therapies, integration of combination and experimental therapies in treatment protocols.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global COVID-19 Current Therapy Market Segmentation

1) By Drug Type: Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs

2) By Route Of Administration: Oral, Intravenous

3) By End-User: Hospitals, Clinics, Home Care, Others

Subsegments:

1) By Antiviral: Remdesivir, Oseltamivir, Favipiravir, Nirmatrelvir Or ritonavir (Paxlovid)

2) By Monoclonal Antibodies: Bamlanivimab, Casirivimab Or Imdevimab (REGEN-COV), Sotrovimab, Etesevimab

3) By Corticosteroid: Dexamethasone, Hydrocortisone, Prednisone

4) By Supplements: Vitamin D, Vitamin C, Zinc, Quercetin

5) By Antimalarial: Hydroxychloroquine, Chloroquine

6) By Interferons and Interleukin Inhibitors: Interferon beta-1a, Interleukin-6 inhibitors

7) By Other Anti-Infective Drugs: Antibiotics, Antifungal Agents

What Is The Driver Of The COVID-19 Current Therapy Market?

The expansion of the healthcare infrastructure is expected to propel the growth of the COVID-19 current therapy market going forward. The healthcare industry refers to amalgamating and integrating the economic system’s sectors that offer products and services for curing, preventing, rehabilitating, and providing palliative care for patients. Healthcare infrastructure is pivotal for the effective implementation of COVID-19 therapies, ensuring timely patient care, supporting research and clinical trials, and providing essential resources for optimal treatment delivery. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the number of hospitals in the US increased to 6,129 from 6,093 in 2022. Furthermore, in May 2023, according to a report published by the Office for National Statistics, a UK-based government department, healthcare spending in the UK saw a significant of 9.4% in nominal terms and 9.7% in real terms. Therefore, the expansion of the healthcare industry is driving the growth of the COVID-19 current therapy industry.

Key Players In The Global COVID-19 Current Therapy Market

Major companies operating in the covid-19 current therapy market are Gilead Sciences Inc., Ipca Laboratories Limited, Zydus Cadila, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, AbbVie, Glenmark Pharmaceuticals Limited, Eli Lilly and Company, Wallace Pharmaceuticals Inc., Canary Health Technologies, Thermo Fisher Scientific

Global COVID-19 Current Therapy Market Trends and Insights

Major companies operating in the COVID-19 current therapy market are increasing their focus on introducing innovative products, such as COVID-19 oral antiviral treatment, to gain a competitive edge in the market. Antiviral treatment refers to the use of medications designed to inhibit the replication and spread of viruses within the body. For instance, in April 2024, Invivyd, a US-based company focuses on developing antibody-based therapies to address serious viral infectious diseases update on the launch of PEMGARDA™. Following its emergency use authorization (EUA) from The U.S. Food and Drug Administration (FDA). PEMGARDA quickly became available for commercial use. This treatment is aimed at preventing COVID-19 in individuals with moderate-to-severe immune compromise.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The COVID-19 Current Therapy Market?

In July 2024, CureVac N.V., a Netherlands-based biotechnology company, partnered with GlaxoSmithKline plc (GSK), to restructure their mRNA vaccine collaboration into a new licensing agreement. With this partnership, CureVac N.V. and GlaxoSmithKline plc (GSK) aim to optimize the development and commercialization of mRNA-based vaccines by combining CureVac’s mRNA technology platform with GSK’s global regulatory, manufacturing, and commercial capabilities, enabling faster vaccine development, improved access, and expanded market reach worldwide. GlaxoSmithKline plc (GSK) is a UK-based pharmaceutical company that specializes in developing and commercializing vaccines, medicines, and consumer healthcare products.

Regional Insights

North America is the largest region in the COVID-19 current therapy market in 2025. Middle East is expected to be the fastest-growing region in the global COVID-19 current therapy market share during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the COVID-19 Current Therapy Market?

The COVID-19 current therapy market includes revenues earned by entities by tocilizumab, favipiravir, and ivermectin. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the COVID-19 Current Therapy Market Report 2026?

The covid-19 current therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the covid-19 current therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

COVID-19 Current Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate CAGR of 33.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Type, Route Of Administration, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Gilead Sciences Inc., Ipca Laboratories Limited, Zydus Cadila, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, AbbVie, Glenmark Pharmaceuticals Limited, Eli Lilly and Company, Wallace Pharmaceuticals Inc., Canary Health Technologie
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. COVID-19 Current Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global COVID-19 Current Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. COVID-19 Current Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global COVID-19 Current Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Antiviral And Monoclonal Antibody Therapies

4.2.2 Increased Use Of Corticosteroids For Severe Covid-19 Cases

4.2.3 Growth In Home Care And Remote Patient Monitoring For Covid-19

4.2.4 Expansion Of Supplement And Immune Support Therapies

4.2.5 Integration Of Combination And Experimental Therapies In Treatment Protocols

5. COVID-19 Current Therapy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Home Care

5.4 Government Healthcare Facilities

5.5 Long-Term Care Centers

6. COVID-19 Current Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global COVID-19 Current Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global COVID-19 Current Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global COVID-19 Current Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global COVID-19 Current Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global COVID-19 Current Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global COVID-19 Current Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. COVID-19 Current Therapy Market Segmentation

9.1. Global COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs

9.2. Global COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous

9.3. Global COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Home Care, Other End-Users

9.4. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Antiviral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Remdesivir, Oseltamivir, Favipiravir, Nirmatrelvir Or Ritonavir (Paxlovid)

9.5. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Bamlanivimab, Casirivimab Or Imdevimab (REGEN-COV), Sotrovimab, Etesevimab

9.6. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Corticosteroid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dexamethasone, Hydrocortisone, Prednisone

9.7. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Supplements, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vitamin D, Vitamin C, Zinc, Quercetin

9.8. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Antimalarial, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hydroxychloroquine, Chloroquine

9.9. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Interferons And Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Interferon Beta-1a, Interleukin-6 Inhibitors

9.10. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Other Anti-Infective Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antibiotics, Antifungal Agents

10. COVID-19 Current Therapy Market Regional And Country Analysis

10.1. Global COVID-19 Current Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global COVID-19 Current Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific COVID-19 Current Therapy Market

11.1. Asia-Pacific COVID-19 Current Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China COVID-19 Current Therapy Market

12.1. China COVID-19 Current Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India COVID-19 Current Therapy Market

13.1. India COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan COVID-19 Current Therapy Market

14.1. Japan COVID-19 Current Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia COVID-19 Current Therapy Market

15.1. Australia COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia COVID-19 Current Therapy Market

16.1. Indonesia COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea COVID-19 Current Therapy Market

17.1. South Korea COVID-19 Current Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan COVID-19 Current Therapy Market

18.1. Taiwan COVID-19 Current Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia COVID-19 Current Therapy Market

19.1. South East Asia COVID-19 Current Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe COVID-19 Current Therapy Market

20.1. Western Europe COVID-19 Current Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK COVID-19 Current Therapy Market

21.1. UK COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany COVID-19 Current Therapy Market

22.1. Germany COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France COVID-19 Current Therapy Market

23.1. France COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy COVID-19 Current Therapy Market

24.1. Italy COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain COVID-19 Current Therapy Market

25.1. Spain COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe COVID-19 Current Therapy Market

26.1. Eastern Europe COVID-19 Current Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia COVID-19 Current Therapy Market

27.1. Russia COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America COVID-19 Current Therapy Market

28.1. North America COVID-19 Current Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA COVID-19 Current Therapy Market

29.1. USA COVID-19 Current Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada COVID-19 Current Therapy Market

30.1. Canada COVID-19 Current Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America COVID-19 Current Therapy Market

31.1. South America COVID-19 Current Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil COVID-19 Current Therapy Market

32.1. Brazil COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East COVID-19 Current Therapy Market

33.1. Middle East COVID-19 Current Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa COVID-19 Current Therapy Market

34.1. Africa COVID-19 Current Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. COVID-19 Current Therapy Market Regulatory and Investment Landscape

36. COVID-19 Current Therapy Market Competitive Landscape And Company Profiles

36.1. COVID-19 Current Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. COVID-19 Current Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. COVID-19 Current Therapy Market Company Profiles

36.3.1. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Ipca Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Zydus Cadila Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

37. COVID-19 Current Therapy Market Other Major And Innovative Companies

AbbVie, Glenmark Pharmaceuticals Limited, Eli Lilly and Company, Wallace Pharmaceuticals Inc., Canary Health Technologies, Thermo Fisher Scientific

38. Global COVID-19 Current Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The COVID-19 Current Therapy Market

40. COVID-19 Current Therapy Market High Potential Countries, Segments and Strategies

40.1 COVID-19 Current Therapy Market In 2030 - Countries Offering Most New Opportunities

40.2 COVID-19 Current Therapy Market In 2030 - Segments Offering Most New Opportunities

40.3 COVID-19 Current Therapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global COVID-19 Current Therapy Market, Overview Of Key Products - Product Examples
  • Table 2: Global COVID-19 Current Therapy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global COVID-19 Current Therapy Market, Supply Chain Analysis
  • Table 4: Global COVID-19 Current Therapy Market, Major Raw Material Providers
  • Table 5: Global COVID-19 Current Therapy Market, Major Resource Providers
  • Table 6: Global COVID-19 Current Therapy Market, Major Manufacturers (Suppliers)
  • Table 7: Global COVID-19 Current Therapy Market, Major Distributors And Channel Partners
  • Table 8: Global COVID-19 Current Therapy Market, Key Technologies & Future Trends
  • Table 9: Global COVID-19 Current Therapy Market, Major Trends
  • Table 10: Global COVID-19 Current Therapy Market, Major End Users
  • Table 11: Global COVID-19 Current Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global COVID-19 Current Therapy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global COVID-19 Current Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global COVID-19 Current Therapy Market - TAM, US$ Billion, 2025
  • Table 15: Global COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Antiviral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Corticosteroid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Supplements, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Antimalarial, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Interferons And Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Other Anti-Infective Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global COVID-19 Current Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global COVID-19 Current Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global COVID-19 Current Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global COVID-19 Current Therapy Market - Company Scoring Matrix
  • Table 101: Gilead Sciences Inc. Financial Performance
  • Table 102: Ipca Laboratories Limited Financial Performance
  • Table 103: Zydus Cadila Financial Performance
  • Table 104: Regeneron Pharmaceuticals Inc. Financial Performance
  • Table 105: Sun Pharmaceutical Industries Limited Financial Performance
  • Table 106: Global COVID-19 Current Therapy Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global COVID-19 Current Therapy Market, Competitive Dashboard
  • Table 108: Global COVID-19 Current Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, COVID-19 Current Therapy Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Table 110: Global, COVID-19 Current Therapy Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 111: Global, COVID-19 Current Therapy Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global COVID-19 Current Therapy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global COVID-19 Current Therapy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global COVID-19 Current Therapy Market, Supply Chain Analysis
  • Figure 4: Global COVID-19 Current Therapy Market, Major Raw Material Providers
  • Figure 5: Global COVID-19 Current Therapy Market, Major Resource Providers
  • Figure 6: Global COVID-19 Current Therapy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global COVID-19 Current Therapy Market, Major Distributors And Channel Partners
  • Figure 8: Global COVID-19 Current Therapy Market, Key Technologies & Future Trends
  • Figure 9: Global COVID-19 Current Therapy Market, Major Trends
  • Figure 10: Global COVID-19 Current Therapy Market, Major End Users
  • Figure 11: Global COVID-19 Current Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global COVID-19 Current Therapy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global COVID-19 Current Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global COVID-19 Current Therapy Market - TAM, US$ Billion, 2025
  • Figure 15: Global COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Antiviral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Corticosteroid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Supplements, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Antimalarial, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Interferons And Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global COVID-19 Current Therapy Market, Sub-Segmentation Of Other Anti-Infective Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global COVID-19 Current Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global COVID-19 Current Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global COVID-19 Current Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global COVID-19 Current Therapy Market - Company Scoring Matrix
  • Figure 101: Gilead Sciences Inc. Financial Performance
  • Figure 102: Ipca Laboratories Limited Financial Performance
  • Figure 103: Zydus Cadila Financial Performance
  • Figure 104: Regeneron Pharmaceuticals Inc. Financial Performance
  • Figure 105: Sun Pharmaceutical Industries Limited Financial Performance
  • Figure 106: Global COVID-19 Current Therapy Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global COVID-19 Current Therapy Market, Competitive Dashboard
  • Figure 108: Global COVID-19 Current Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, COVID-19 Current Therapy Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Figure 110: Global, COVID-19 Current Therapy Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 111: Global, COVID-19 Current Therapy Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Global Gonadotropin-Releasing Hormone (GnRH) Agonists And Antagonists Drugs Market Forecast to Reach $2.49 Billion by 2029, Driven by 9.5% CAGR

Read More About Global Gonadotropin-Releasing Hormone (GnRH) Agonists And Antagonists Drugs Market Forecast to Reach $2.49 Billion by 2029, Driven by 9.5% CAGR

Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

Read More About Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

CAGR of 11.4% Projected for Protein Purification and Isolation Market From 2025 to 2029

Read More About CAGR of 11.4% Projected for Protein Purification and Isolation Market From 2025 to 2029

Emerging Trends and Growth Drivers in the Pulmonary Arterial Hypertension Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Pulmonary Arterial Hypertension Market Through 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

COVID-19 Rapid Test Kits Market 2022 – By Test Type (RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Others), By Test Components (PCR Machines, Equipment And Extraction Kits, Reagents), By Specimen Type (Nasopharyn...

Pediatric Vaccine Market 2025 – By Vaccine Type (Monovalent Vaccines, Multivalent Vaccines), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Conjugate Vaccines, Other Technologies), By App...

Preventive Healthcare Technologies And Services Market Report 2026 - Global Outlook – By Type (Early Detection and Screening Technologies, Vaccines, Chronic Disease Management Technologies, Advanced Technologies), By App...

Hydroxychloroquine Market Report 2026 - Global Outlook – By Drug Activity (Anti-Malarial Drug, Anti-Rheumatic Drug, Lupus Suppressant Drug, Anti COVID-19 Drug, Other Drug Activity), By Formulation (Tablets, Injection ), ...

COVID-19 Detection Test Kits and Consumables Market Report 2026 - Global Outlook – By Kits (Viral Load Testing Kits (qPCR and RT-PCR), Virus Neutralizing Assay Kits, Antibody Detection Kits (Elisa), Viral Antigen Detecti...

COVID-19 Rapid Test Kits Market Report 2026 - Global Outlook – By Test Type (RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Other Test Types), By Specimen Type (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab,...

DTP Vaccines Market Report 2026 - Global Outlook – By Product Type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End-User (Hospitals, Clinics, Vaccination Centers) - Market Size, Trends, And Global Fo...

Biologics Market Report 2026 - Global Outlook – By Type (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines ), By Drug Classification (Branded Drugs, Generic Drugs ), By Route Of Administration (Oral, Other Rou...

Frequently Asked Questions

The COVID-19 Current Therapy market was valued at $2.35 billion in 2025, increased to $1.57 billion in 2026, and is projected to reach $0.31 billion by 2030.

The global COVID-19 Current Therapy market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $0.31 billion by 2035.

Some Key Players in the COVID-19 Current Therapy market Include, Gilead Sciences Inc., Ipca Laboratories Limited, Zydus Cadila, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, AbbVie, Glenmark Pharmaceuticals Limited, Eli Lilly and Company, Wallace Pharmaceuticals Inc., Canary Health Technologies, Thermo Fisher Scientific .

Major trend in this market includes: Innovation In COVID-19 Therapies On Oral Antiviral Treatments By Major Pharmaceutical Companies. For further insights on this market. request a sample here

North America is the largest region in the COVID-19 current therapy market in 2025. Middle East is expected to be the fastest-growing region in the global COVID-19 current therapy market share during the forecast period. The regions covered in the covid-19 current therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us